Pfizer Q4 and Full Year Report 2013

PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2013 RESULTS;
PROVIDES 2014 FINANCIAL GUIDANCE

• Fourth-Quarter 2013 Reported Revenues of $13.6 Billion (13.9), Full-Year 2013 Reported Revenues of $51.6 Billion (54.7).

• Fourth-Quarter 2013 Adjusted Diluted EPS of $0.56 (0.46), Reported Diluted EPS of $0.39 (0.89), Full-Year 2013 Adjusted Diluted EPS of $2.22 (2.10), Reported Diluted EPS(1) of $3.19 (1.94).

• Repurchased $4.6 Billion and $16.3 Billion of Common Stock in Fourth-Quarter and Full-Year 2013, Respectively; Returned Approximately $23 Billion to Shareholders Through Share Repurchases and Dividends in 2013.

Pfizer's 2014 financial guidance:

• Adjusted Revenues: $49.2 to $51.2 billion
• Reported Diluted EPS: $1.57 to $1.72
• Adjusted Diluted EPS: $2.20 to $2.30

For more information, click the link below
Pfizer Q4-2013

Intel Q4 and Full Year Report 2013

Intel Reports Full-Year Revenue of $52.7 Billion, Net Income of $9.6 Billion
Generates $21 Billion in Cash from Operations

 

• Operating income of $3.5 billion, up 12 percent year-over-year
• EPS of 51 cents, up 6 percent year-over-year
• PC Client Group revenue of $8.6 billion, flat year-over-year
• Data Center Group revenue of $3.0 billion, up 8 percent year-over-year

 For more information, click the link below

Intel Q4-2013 

Recent Buy Philip Morris International Inc. PM

17th January 2014 I Bought 85 shares of PM at $83.49 per share plus commission.

Philip Morris International Inc. (PMI) is a holding company. PMI’s subsidiaries and affiliates and their licensees are engaged in the manufacture and sale of cigarettes and other tobacco products in markets outside of the United States of America. Its products are sold in approximately 180 countries. The Company divides its markets into four geographic segments: The European Union (EU) Region , The Eastern Europe, Middle East & Africa (EEMA) Region , The Asia Region and The Latin America & Canada Region.

Review of the Year 2013 and goals for the next year

Year 2013 is behind us, so it's time to look at what happened to my portfolio during the year.

I did  24 transactions during the year, 21 purchases and 3 sales , I got dividends from 21 companies.
In January, I sold my 200 Orion's shares. because in my view, their value had risen too high. I left, however, a further 300 Orion's shares in my portfolio, because I still believe in Orion's ability to pay good dividends. In February, I sold about 73% of the SP corporate bond fund, because I wanted to move the weight more on direct equity investments. The third-sales I made in December, I reduced the number of my holding in Tele2, from my 500 shares, I sold 300 shares, because I'm a little skeptical of Tele2's ability to pay good dividends for years to come. These sales generated a total of  €8,069 income, after-tax, my net income will be € 5,648.44.

December Dividend Income

In December, the portfolio dividend income was as follows:

PFE $48.00
INTC $90.00
SDIV $74.10
KO $42.00
GLNG $135.00
TAL $70.00
Total income was €334.93 ($459.10), after tax my net income will be €259.74.

Dividend Increases in December

13th December 2013 AT&T Inc. announced that its board of directors has approved a 2.2 percent increase in the company’s quarterly dividend to stockholders.
AT&T directors increased the quarterly dividend rate from $0.45 to $0.46 a share on a quarterly basis, or an increase from $1.80 to $1.84 a share on an annualized basis.
The dividend will be payable on Feb. 3, 2014 to common stockholders of record on Jan. 10, 2014.

16th December 2013 the board of directors of Pfizer Inc. declared a 26-cent first-quarter 2014 dividend on the company’s common stock, payable March 4, 2014, to shareholders of record at the close of business on February 7, 2014.  Pfizer increased the dividend by more than 8 percent, to 26 cents from 24 cents per share.

“The dividend increase is a testament to our continued commitment to returning capital to shareholders and our confidence in the business,” stated Ian Read, Pfizer chairman and chief executive officer.  “As always, we are focused on maximizing total shareholder return, of which the dividend is a key component.”
 

Golar LNG Interim Report January–September 2013

 Q3 HIGHLIGHTS

 

• Golar reports a third quarter 2013 net loss of $13.1 million (including a non-cash loss of $8.2 million on interest rate swaps) 
• EBITDA generated in the quarter amounts to loss of $3.3 million but cash from operating activities improves from Q2 level to $23m in 
• Q3 Golar concludes $1.1 billion funding facility for eight of its thirteen newbuilds 
• Ten year FSRU time charter for the Golar Eskimo concluded with the Heshemite Kingdom of Jordan Five year FSRU time charter for the Golar Igloo concluded with the Kuwait National Petroleum Company 
• Golar Tundra shipbuilding contract amended to include FSRU capability with a revised delivery date of November 2015 
• Spot charter rates hold firm but market remains volatile and inefficient – as a result Gimi and Viking experience prolonged periods of offhire 
• Board maintains dividend at $0.45 for the quarter

For more information, click the link below
Golar LNG Q3-2013